⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2025Open Access

Supplemental Table S8 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

Joanna Poźniak Niccolò Roda Ewout Landeloos Asier Antoranz Yannick Van Herck Amber De Visscher Philip Georg Demaerel Lukas Vanwynsberghe Jeroen Declercq Christos Gkemisis Greet Bervoets No‐Joon Song Ayse Bassez Robin Browaeys Lotte Pollaris Francesca M. Bosisio Veerle Boecxstaens Yvan Saeys Diether Lambrechts Zihai Li Patrick Matthys Oliver Bechter Jean‐Christophe Marine

View Full Paper

Ask AI

Bookmark

Share

Key Points

Cytotoxic nk cells hinder checkpoint immunotherapy effectiveness in melanoma with an immune-excluded phenotype.
Key evidence shows that specific antibodies listed for the milano experiment are involved.
Observational analysis investigates the interaction between immune response and cancer treatment in melanoma.
This indicates the potential need for targeted therapies to enhance treatment efficacy.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Analysis highlights how cytotoxic nk cells impede response to checkpoint immunotherapy in melanoma, suggesting new strategies may be needed.

Abstract

List of antibodies used for the MILAN experiment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Poźniak et al. (2025) studied this question.

synapsesocial.com/papers/68c18f2a9b7b07f3a0615403 https://doi.org/10.1158/2159-8290.30050712

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table S12 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
2Supplemental Table S13 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
3Supplemental Table S1 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
4Supplemental Table S2 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
5Supplemental Table S9 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025

More related papers

Supplemental Table S3 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
Supplemental Table S4 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025
Supplemental Table S11 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype2025